Citation Impact
Citing Papers
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
High prevalence of benzodiazepine dependence in out‐patient users, based on the DSM‐III‐R and ICD‐10 criteria
1997
Cytochrome P450 3A5 Genotype is Associated with Verapamil Response in Healthy Subjects
2007
Haematological toxicity of drugs used in psychiatry
2007
Rodent data and general hypothesis: antipsychotic action exerted through 5-HT2A receptor antagonism is dependent on increased serotonergic tone
1998 StandoutNobel
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
2005 Standout
Neuroreceptor imaging in psychiatric disorders
2002
Switching From Clozapine to Zotepine in Patients With Schizophrenia
2013
Bruxism physiology and pathology: an overview for clinicians*
2008 Standout
Descending control of pain
2002 Standout
Twelve-Month Use of Mental Health Services in the United States
2005 Standout
Association Between CYP2C9 Genetic Variants and Anticoagulation-Related Outcomes During Warfarin Therapy
2002 Standout
Description and Epidemiology of Nursing Caries
1996
Sex Differences in Pharmacokinetics and Pharmacodynamics
2009
Effects of diazepam on conditioned place preference induced by morphine or amphetamine in the rat
2000
The Th2-hypothesis of schizophrenia: a strategy to identify a subgroup of schizophrenia caused by immune mechanisms
2001
QSAR Studies of CYP2D6 Inhibitor Aryloxypropanolamines Using 2D and 3D Descriptors
2009
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
2012
Drug-Induced Hepatotoxicity
2003 Standout
The Influence of Age and Sex on the Clearance of Cytochrome P450 3A Substrates
2005
REVIEW ON CPP: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade
2007 Standout
Sex bias in neuroscience and biomedical research
2010 Standout
Sleep quality and the use of benzodiazepine hypnotics in general practice
1995
State of the art in hair analysis for detection of drug and alcohol abuse
2006 Standout
New Insights into the Biology of Schizophrenia through the Mechanism of Action of Clozapine
1995
Network interactions in schizophrenia — therapeutic implications
2000 StandoutNobel
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Long-term treatment of schizophrenia
2006
Clinical and Biologic Response to Clozapine in Patients With Schizophrenia
1992
CYP2D6 polymorphisms and the risk of tardive dyskinesia in schizophrenia: a meta-analysis
2005
Potential Role of Pharmacogenomics in Reducing Adverse Drug Reactions
2001
Neopterin and Macrophage Inflammatory Protein-1α in the Cerebrospinal Fluid of Schizophrenic Patients: No Evidence of Intrathecal Inflammation
2002
Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
2011 Standout
Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia
2002 Standout
Metabolic Drug Interactions with Newer Antipsychotics: A Comparative Review
2006
Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development
2003
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
2009 Standout
Does Fast Dissociation From the Dopamine D2Receptor Explain the Action of Atypical Antipsychotics?: A New Hypothesis
2001
Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement
1999 Standout
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
2001 Standout
Cholinergic Hyperactivity and Negative Schizophrenic Symptoms
1989
Dopamine D2 receptor occupancy by risperidone: Implications for the timing and magnitude of clinical response
2006
CLASSICAL AND ATYPICAL NEUROLEPTICS, AND BONE MINERAL DENSITY, IN PATIENTS WITH SCHIZOPHRENIA
2002
Neurotransmitter interactions in schizophrenia—therapeutic implications
1999 StandoutNobel
Non‐medical use of prescription stimulants among US college students: prevalence and correlates from a national survey
2004 Standout
Mycotoxins and human disease: a largely ignored global health issue
2009 Standout
Sexual dysfunction and antipsychotic treatment
2002
Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
2011 Standout
Mycotoxins: Occurrence, toxicology, and exposure assessment
2013 Standout
Clozapine dose–concentration relationships in plasma, hair and sweat specimens of schizophrenic patients
2000
Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials
1999
Neurotransmitter aberrations in schizophrenia: New perspectives and therapeutic implications
1997 StandoutNobel
MK-801-induced hyperlocomotion: Differential effects of M100907, SDZ PSD 958 and raclopride
1997 StandoutNobel
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
The Current State of Knowledge on Age, Sex, and Their Interactions on Clinical Pharmacology
2007
The role of 5-HT2A receptors in antipsychotic activity
1995
Epidemiology of insomnia: what we know and what we still need to learn
2002 Standout
Plants and the central nervous system
2003 Standout
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
Mycotoxin problem in Africa: Current status, implications to food safety and health and possible management strategies
2008 Standout
The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies
2001 Standout
A Meta-analysis of the Efficacy of Second-Generation Antipsychotics
2003
Neurocognitive deficit in schizophrenia: A quantitative review of the evidence.
1998 Standout
Metabolic side effects of antipsychotic medication
2007
Gender differences in drug responses
2006
Further exploring r metrics for validation of QSPR models
2011 Standout
Abnormal neural oscillations and synchrony in schizophrenia
2010 Standout
Sex Differences in Pharmacokinetics and Pharmacodynamics
2004
Schizophrenia, Obesity, and Antipsychotic Medications: What Can We Do?
2008
Policy: NIH to balance sex in cell and animal studies
2014 StandoutNature
Risk Factors Associated With Problem Use of Prescription Drugs
2004
Oral dyskinesia: a clinical overview.
2005
Review and management of clozapine side effects.
2000
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
Pramipexole in Psychiatry
2007
A glutamatergic deficiency model of schizophrenia
1999 StandoutNobel
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Acute treatment of schizophrenia
2005
Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture
2011 StandoutNobel
Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT Gene
2003 StandoutScience
Fumonisin b1 carcinogenicity in a two-year feeding study using F344 rats and B6C3F1 mice.
2001
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
Engineered Bacterial Mimics of Human Drug Metabolizing Enzyme CYP2C9
2011 StandoutNobel
Pharmacologic and Therapeutic Considerations in Hypertension Therapy With Calcium Channel Blockers: Focus on Verapamil
2007
A systematic review of atypical antipsychotic drugs in schizophrenia
2003
A faulty negative feedback control underlies the schizophrenic syndrome?
1991 StandoutNobel
The Neuropsychology of Anxiety
2003 Standout
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
1999 StandoutScience
The Role of Bacteria in the Caries Process
2010 Standout
Psychotropic Drugs, Cardiac Arrhythmia, and Sudden Death
2003
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Variation in CYP1A2 Activity and its Clinical Implications: Influence of Environmental Factors and Genetic Polymorphisms
2008
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
The neuropsychology of schizophrenia
1991
Works of C. Barnas being referenced
Dopamine- and serotonin-receptors in schizophrenia: results of imaging-studies and implications for pharmacotherapy in schizophrenia
1999
In vivo 123 I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol
1999
Treatment of schizophrenic disorders: Algorithms for acute pharmacotherapy
1997
Characteristics of benzodiazepine long-term users: investigation of benzodiazepine consumers among pharmacy customers
1991
Is schizophrenia linked to alteration in cellular immunity?
1989
Efficacy, cardiac safety and tolerability of sertindole: a drug surveillance
2000
Genetic polymorphisms for drug metabolism (CYP2D6) and tardive dyskinesia in schizophrenia
1998
Pramipexole as adjunct to haloperidol in schizophrenia
1997
In vivo comparison of putative probes of CYP3A4/5 activity: Erythromycin, dextromethorphan, and verapamil
1999
The Role of Carbamazepine in the Prophylaxis of Unipolar Depression
1993
Zotepine in the treatment of schizophrenic patients with prevailingly negative symptoms. A double-blind trial vs. haloperidol
1992
Sertindole and dopamine D 2 receptor occupancy in comparison to risperidone, clozapine and haloperidol - a 123 I-IBZM SPECT study
1998
Clozapine plasma levels determined by high-performance liquid chromatography with ultraviolet detection
1988
Gender‐Specific Effects on Verapamil Pharmacokinetics and Pharmacodynamics in Humans
2000
Epidemiology of benzodiazepine dependence
1986
The Effect of Orlistat on Plasma Levels of Psychotropic Drugs in Patients With Long-term Psychopharmacotherapy
2002
Transient neutropenia induced by clozapine.
1992
Clozapine-induced transient white blood count disorders.
1994
Influence of patient-related variables on clozapine plasma levels
1990
A Mechanistic Basis for the Beneficial Effects of Caloric Restriction On Longevity and Disease: Consequences for the Interpretation of Rodent Toxicity Studies
1998
Zotepine vs. haloperidol in paranoid schizophrenia: a double-blind trial.
1989
Zotepine in the Treatment of Negative Symptoms in Chronic Schizophrenia
1987
Granulocyte-macrophage colony-stimulating factor (GM-CSF) treatment of clozapine-induced agranulocytosis: a case report.
1992
BENZODIAZEPINES AND OTHER PSYCHOTROPIC DRUGS ABUSED BY PATIENTS IN A METHADONE MAINTENANCE PROGRAM: FAMILIARITY AND PREFERENCE.
1992